Study to Understand Risk Information to Support and Empower (SUNRISE)

November 13, 2023 updated by: University of California, Davis

Optimizing a Scalable Intervention to Maximize Guideline-recommended Diabetes Testing After GDM

The aim of this trial is to test components of a digital health outreach intervention to promote uptake of postpartum screening and lifestyle programs for diabetes prevention among patients with gestational diabetes (GDM). The outreach intervention, designed to be interactive and delivered online, includes standard health information plus up to four theory-based components, targeting motivational and logistical barriers to engaging in diabetes preventive care during the postpartum period. The trial leverages the Multiphase Optimization Strategy (MOST) using a randomized factorial study design.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

2000

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Oakland, California, United States, 94612
        • Kaiser Permanente Northern California

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Current pregnancy complicated by gestational diabetes mellitus (GDM)
  • Age: 18 years and older
  • Contact with the Kaiser Permanente Northern California (KPNC) Regional Perinatal Service Center
  • Able to communicate in English

Exclusion Criteria:

  • Diagnosis of diabetes before pregnancy
  • Maternal or infant current hospitalization
  • Pregnancy loss
  • History of eating disorder
  • Previously requested not to receive research invitations

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Condition 1
Standard health message + VA + TRI + MI+ AP
Standard health information about postpartum screening and lifestyle programs for diabetes prevention
Interactive prompts to reflect on core personal values
Interactive prompts to provide tailored information on risk factors for type 2 diabetes
Interactive prompts based on principles of motivational interviewing
Interactive prompts to problem solve challenges
Experimental: Condition 2
Standard health message + VA + TRI + MI
Standard health information about postpartum screening and lifestyle programs for diabetes prevention
Interactive prompts to reflect on core personal values
Interactive prompts to provide tailored information on risk factors for type 2 diabetes
Interactive prompts based on principles of motivational interviewing
Experimental: Condition 3
Standard health message + VA + TRI + AP
Standard health information about postpartum screening and lifestyle programs for diabetes prevention
Interactive prompts to reflect on core personal values
Interactive prompts to provide tailored information on risk factors for type 2 diabetes
Interactive prompts to problem solve challenges
Experimental: Condition 4
Standard health message + VA + TRI
Standard health information about postpartum screening and lifestyle programs for diabetes prevention
Interactive prompts to reflect on core personal values
Interactive prompts to provide tailored information on risk factors for type 2 diabetes
Experimental: Condition 5
Standard health message + VA + MI+ AP
Standard health information about postpartum screening and lifestyle programs for diabetes prevention
Interactive prompts to reflect on core personal values
Interactive prompts based on principles of motivational interviewing
Interactive prompts to problem solve challenges
Experimental: Condition 6
Standard health message + VA + MI
Standard health information about postpartum screening and lifestyle programs for diabetes prevention
Interactive prompts to reflect on core personal values
Interactive prompts based on principles of motivational interviewing
Experimental: Condition 7
Standard health message + VA + AP
Standard health information about postpartum screening and lifestyle programs for diabetes prevention
Interactive prompts to reflect on core personal values
Interactive prompts to problem solve challenges
Experimental: Condition 8
Standard health message + VA
Standard health information about postpartum screening and lifestyle programs for diabetes prevention
Interactive prompts to reflect on core personal values
Experimental: Condition 9
Standard health message + TRI + MI+ AP
Standard health information about postpartum screening and lifestyle programs for diabetes prevention
Interactive prompts to provide tailored information on risk factors for type 2 diabetes
Interactive prompts based on principles of motivational interviewing
Interactive prompts to problem solve challenges
Experimental: Condition 10
Standard health message + TRI + MI
Standard health information about postpartum screening and lifestyle programs for diabetes prevention
Interactive prompts to provide tailored information on risk factors for type 2 diabetes
Interactive prompts based on principles of motivational interviewing
Experimental: Condition 11
Standard health message + TRI + AP
Standard health information about postpartum screening and lifestyle programs for diabetes prevention
Interactive prompts to provide tailored information on risk factors for type 2 diabetes
Interactive prompts to problem solve challenges
Experimental: Condition 12
Standard health message + TRI
Standard health information about postpartum screening and lifestyle programs for diabetes prevention
Interactive prompts to provide tailored information on risk factors for type 2 diabetes
Experimental: Condition 13
Standard health message + MI+ AP
Standard health information about postpartum screening and lifestyle programs for diabetes prevention
Interactive prompts based on principles of motivational interviewing
Interactive prompts to problem solve challenges
Experimental: Condition 14
Standard health message + MI
Standard health information about postpartum screening and lifestyle programs for diabetes prevention
Interactive prompts based on principles of motivational interviewing
Experimental: Condition 15
Standard health message + AP
Standard health information about postpartum screening and lifestyle programs for diabetes prevention
Interactive prompts to problem solve challenges
Experimental: Condition 16
Standard health message
Standard health information about postpartum screening and lifestyle programs for diabetes prevention

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Completion of recommended postpartum diabetes screening.
Time Frame: 4-12 weeks postpartum
Completion of a 75-gram, 2-hour oral glucose tolerance test (OGTT)
4-12 weeks postpartum

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Completion of any recommended postpartum diabetes screening test.
Time Frame: 4-52 weeks postpartum
Completion of any screening test (OGTT, fasting plasma glucose, or HbA1c)
4-52 weeks postpartum
Uptake of a lifestyle program for diabetes prevention.
Time Frame: 4-52 weeks postpartum
Enrollment in a lifestyle program for diabetes prevention among women without type 2 diabetes mellitus according to any screening result
4-52 weeks postpartum

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Susan D Brown, PhD, University of California, Davis

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 13, 2023

Primary Completion (Estimated)

September 1, 2025

Study Completion (Estimated)

February 1, 2026

Study Registration Dates

First Submitted

February 16, 2023

First Submitted That Met QC Criteria

February 28, 2023

First Posted (Actual)

March 2, 2023

Study Record Updates

Last Update Posted (Actual)

November 15, 2023

Last Update Submitted That Met QC Criteria

November 13, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diabetes Mellitus, Type 2

Clinical Trials on Standard Health Information

3
Subscribe